NSEShareholders meeting10 Jul 2026 · 10 Jul 2026, 04:20 pm
Shareholders meeting
Alembic Pharmaceuticals Limited · APLLTD
✦ AI Summaryshareholders_meeting
Alembic Pharmaceuticals Limited has informed the Exchange regarding Notice of 16th Annual General Meeting to be held on August 05, 2026. The meeting will consider various resolutions including appointment of a director, dividend declaration, and ratification of remuneration to the cost auditors.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Alembic Pharmaceuticals Limited has informed the Exchange regarding Notice of 16th Annual General Meeting to be held on August 05, 2026 at 4:00 p.m. IST.
Attachments (1)
📄pdf
Download →
APLLTD_10072026162000_Submission_of_Notice_of_the_16th_AGM_S.pdf
View document text
Date: 10th July, 2026
To, To,
The Manager, The Manager,
Department of Corporate Services, Listing Department,
BSE Limited National Stock Exchange of India Ltd.
P. J. Towers, Dalal Street, ‘Exchange Plaza’, Bandra Kurla Complex,
Fort, Mumbai – 400 001 Bandra (E), Mumbai – 400 051
Scrip Code: 533573 NSE Symbol: APLLTD
Dear Sir/Madam,
Sub: Submission of Notice of the 16th Annual General Meeting of the Company.
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015, we enclose herewith Notice of the 16th Annual General Meeting of the
Members of the Company scheduled to be held on Wednesday, the 5th August, 2026 at 4:00
p.m. IST through Video Conferencing (“VC”) / Other Audio Visual Means (“OAVM”).
We request you to kindly take the same on record.
Thanking you,
Yours faithfully,
For Alembic Pharmaceuticals Limited
Manisha Saraf
Company Secretary
Encl.: A/a.
ALEMBIC PHARMACEUTICALS LIMITED
REGD. OFFICE: ALEMBIC ROAD, VADODARA - 390 003. ● TEL: (0265) 2280550, 2280880 ● FAX: (0265) 2281229
Website : www.alembicpharmaceuticals.com ● E-mail : alembic@alembic.co.in ● CIN : L24230GJ2010PLC061123
Alembic Pharmaceuticals Limited
CIN: L24230GJ2010PLC061123
Regd. Office: Alembic Road, Vadodara - 390 003
Tel: +91 265 6637300
Website: www.alembicpharmaceuticals.com | E-mail: apl.investors@alembic.co.in
Notice
Notice is hereby given that the 16th Annual General Meeting Mr. Sujit Jaysukh Bhayani (DIN: 01767427), who was
(“AGM”) of the Members of Alembic Pharmaceuticals Limited appointed as an Additional Director, designated as an
will be held on Wednesday, 5th August, 2026 at 4:00 p.m. Independent Director of the Company w.e.f. 18th June,
IST through Video Conferencing (“VC”) / Other Audio Visual 2026, and who has submitted a declaration that he meets
Means (“OAVM”) to transact the following business: the criteria of independence under Section 149(6) of the
Act & Regulation 16(1)(b) of the SEBI Listing Regulations,
Ordinary Business
2015, and in respect of whom the Company has received
1. To receive, consider and adopt: a notice in writing under Section 160 of the Act from a
a) the Audited Standalone Financial Statements of the member proposing his candidature for the office of
Company for the financial year ended 31st March, Director, be and is hereby appointed as an Independent
2026 together with the Reports of the Board of Director of the Company, not liable to retire by rotation,
Directors and Auditors thereon. to hold office for a term of 5 (five) consecutive years from
the date of his appointment i.e. from 18th June, 2026 upto
b) the Audited Consolidated Financial Statements of
17th June, 2031.
the Company for the financial year ended 31st March,
2026 together with the Reports of the Auditors
RESOLVED FURTHER THAT the Board of Directors of the
thereon.
Company and or any person authorised by the Board be
and is hereby authorized to do all acts, deeds and things,
2. To declare Dividend on equity shares for the financial year
necessary and expedient to give effect to this resolution.”
2025-26.
5. Ratification of Remuneration to the Cost Auditors for
3. To appoint a Director in place of Mr. Pranav Amin (DIN:
the financial year 2026-27:
00245099), who retires by rotation and being eligible,
offers himself for re-appointment. To consider and if thought fit, to pass, the following
Resolution as an Ordinary Resolution:
Special Business
“RESOLVED THAT pursuant to the provisions of Section 148
4. Appointment of Mr. Sujit Jaysukh Bhayani (DIN: and other applicable provisions, if any, of the Companies
01767427) as an Independent Director of the Company: Act, 2013 (‘the Act’) read with rules framed thereunder
To consider and if thought fit, to pass, the following (including any statutory modification(s) / amendment(s)
Resolution as a Special Resolution: / re-enactment(s) thereto), the remuneration payable
to M/s. Diwanji & Co., Cost & Management Accountants
“RESOLVED THAT pursuant to the provisions of Sections
having Firm Registration No. 000339, appointed by the
149, 150, 152, read with Schedule IV and other applicable
Board of Directors of the Company, to conduct the audit
provisions of the Companies Act, 2013 (“the Act”), the
of the cost records of the Company for the financial year
Companies (Appointment and Qualifications of Directors)
2026-27, amounting to H2.75 Lacs plus applicable tax,
Rules, 2014 and Regulations 17(1C), 25(2A) and other
travelling and other out-of-pocket expenses incurred by
applicable provisions of the Securities and Exchange Board
them in connection with the aforesaid audit, be and is
of India (Listing Obligations and Disclosure Requirements)
hereby ratified and confirmed.”
Regulations, 2015 (“SEBI Listing Regulations, 2015”)
(including any statutory modification(s) or re-enactment
NOTES:
thereto), the Articles of Association of the Company
1. Pursuant to the General Circular No. 14/2020 dated
and on the basis of the recommendation of Nomination
April 8, 2020, 17/2020 dated April 13, 2020, 20/2020 dated
and Remuneration Committee (“NRC”) and approval
May 5, 2020 resting with 03/2025 dated September 22,
by the Board of Directors of the Company (“Board”),
ANNUAL REPORT 01
25/26
2025, issued by the Ministry of Corporate Affairs (MCA) 6. The details of the Director seeking appointment/
and circular issued by SEBI vide circular no. SEBI/HO/ re-appointment at the AGM, pursuant to the provisions of
CFD/CFDPoD-2/P/CIR/2024/133 dated October 3, 2024 Regulation 36(3) of the SEBI Listing Regulations, 2015, para
and Master Circular No. HO/49/14/14(7)2025-CFD- 1.2.5 of the Secretarial Standards on General Meetings
POD2/I/3762/2026 dated January 30, 2026 (“SEBI Circular”) (SS-2) and other applicable provisions, are provided in
and other applicable circulars and notifications issued Annexure - A to this Notice.
(including any statutory modifications or re-enactments
7. All documents referred to in the Notice will also be
thereof for the time being in force and as amended
available electronically for inspection without any fee
from time to time, companies are allowed to hold EGM/
by the members from the date of circulation of this
AGM through Video Conferencing (VC) or other audio
Notice up to the date of AGM. The Register of Directors
visual means (OAVM), without the physical presence of
and Key Managerial Personnel and their shareholding,
members at a common venue. In compliance with the
maintained under Section 170 of the Act and the Register
said Circulars, EGM/AGM shall be conducted through
of Contracts or Arrangements in which the directors
VC/OAVM. Hence, in compliance with the Circulars, the
are interested maintained under Section 189 of the Act,
AGM of the Company will be held through VC/OAVM.
will be available for inspection, electronically, by the
The registered office of the Company shall be deemed to
members of the Company. Members seeking to inspect
be the venue for the AGM.
such documents can send a request from their registered
2. Since this AGM is being held through VC/OAVM, pursuant email-ID mentioning their name, DP ID and Client ID / Folio
to the Circulars, physical attendance of the members No., PAN and Mobile No. to the Company at
has been dispensed with. Accordingly, the facility for apl.investors@alembic.co.in.
appointment of proxies by the members will not
8. The Company has fixed Wednesday, 29th July, 2026 as the
be available for the AGM. Hence the Proxy Form,
“record date” for determining the entitlement of Members
Attendance Slip and Route Map are not annexed to
to final dividend for the financial year ended 31st March,
this Notice. However, the Body Corporates are entitled
2026, if approved at the AGM.
to appoint authorised representatives to attend the AGM
through VC/OAVM and participate therein and cast their 9. The dividend when sanctioned will be made payable on
votes through e-voting. or from 6th August, 2026, till the time stipulated under the
Act for the payment of Dividend
[Showing first 8,000 characters — download PDF for full document]